Xylem Inc. (XYL) Upgraded to Overweight at Barclays PLC

Xylem Inc. (NYSE:XYL) was upgraded by equities research analysts at Barclays PLC from an “equal weight” rating to an “overweight” rating in a research report issued on Monday, May 15th, MarketBeat reports. The brokerage presently has a $59.00 price target on the industrial products company’s stock, up from their previous price target of $51.00. Barclays PLC’s price objective suggests a potential upside of 9.16% from the company’s current price.

A number of other equities analysts have also issued reports on XYL. Canaccord Genuity reaffirmed a “hold” rating and set a $50.00 price target on shares of Xylem in a research note on Wednesday, February 8th. Zacks Investment Research raised Xylem from a “sell” rating to a “hold” rating in a research note on Monday, February 6th. Boenning Scattergood raised Xylem from a “neutral” rating to an “outperform” rating and set a $55.00 price target for the company in a research note on Friday, February 3rd. Oppenheimer Holdings, Inc. reaffirmed a “buy” rating on shares of Xylem in a research note on Tuesday, May 9th. Finally, CIBC reissued a “buy” rating on shares of Xylem in a research note on Wednesday, May 10th. Six investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $55.18.

Analyst Recommendations for Xylem (NYSE:XYL)

Xylem (NYSE XYL) traded up 0.17% during mid-day trading on Monday, reaching $54.05. The company’s stock had a trading volume of 1,607,084 shares. Xylem has a 52 week low of $42.52 and a 52 week high of $54.99. The firm has a market capitalization of $9.71 billion, a P/E ratio of 38.88 and a beta of 1.15. The firm’s 50 day moving average price is $52.28 and its 200 day moving average price is $50.23.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, May 2nd. The industrial products company reported $0.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.01. The firm had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.05 billion. Xylem had a return on equity of 15.53% and a net margin of 6.75%. The firm’s quarterly revenue was up 26.4% on a year-over-year basis. During the same period last year, the company posted $0.35 EPS. On average, analysts anticipate that Xylem will post $2.31 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 21st. Stockholders of record on Thursday, May 25th will be given a $0.18 dividend. The ex-dividend date is Tuesday, May 23rd. This represents a $0.72 annualized dividend and a dividend yield of 1.33%. Xylem’s dividend payout ratio (DPR) is presently 50.35%.

ILLEGAL ACTIVITY WARNING: This story was first posted by Markets Daily and is owned by of Markets Daily. If you are viewing this story on another website, it was copied illegally and reposted in violation of U.S. and international copyright law. The original version of this story can be read at https://www.themarketsdaily.com/2017/06/17/xylem-inc-xyl-rating-increased-to-overweight-at-barclays-plc-updated-updated-updated.html.

In other news, insider Tomas Brannemo sold 14,080 shares of the firm’s stock in a transaction on Thursday, May 4th. The stock was sold at an average price of $50.36, for a total value of $709,068.80. Following the completion of the sale, the insider now owns 21,000 shares of the company’s stock, valued at $1,057,560. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.75% of the company’s stock.

Several hedge funds have recently modified their holdings of the company. Asset Planning Services Ltd. boosted its stake in shares of Xylem by 2,000.0% in the fourth quarter. Asset Planning Services Ltd. now owns 2,100 shares of the industrial products company’s stock valued at $104,000 after buying an additional 2,000 shares during the period. Contravisory Investment Management Inc. boosted its stake in shares of Xylem by 96.1% in the first quarter. Contravisory Investment Management Inc. now owns 2,345 shares of the industrial products company’s stock valued at $118,000 after buying an additional 1,149 shares during the period. Cribstone Capital Management LLC boosted its stake in shares of Xylem by 1,214.6% in the first quarter. Cribstone Capital Management LLC now owns 2,432 shares of the industrial products company’s stock valued at $124,000 after buying an additional 2,247 shares during the period. Advisor Group Inc. boosted its stake in shares of Xylem by 10.0% in the third quarter. Advisor Group Inc. now owns 2,493 shares of the industrial products company’s stock valued at $131,000 after buying an additional 227 shares during the period. Finally, FNY Partners Fund LP acquired a new stake in shares of Xylem during the first quarter valued at approximately $151,000. 85.57% of the stock is owned by institutional investors and hedge funds.

Xylem Company Profile

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply